1. Goserelin fosters bone elongation but does not prevent ovarian damage in cyclophosphamide-treated prepubertal mice 
Laura Detti, M.D., Rebecca A. Uhlmann, M.S., Jie Zhang, M.D., Michael P. Diamond, M.D., Ghassan M. Saed, Ph.D., Nicole M. Fletcher, Ph.D., Meifen Lu, B.S., Lucy J. Williams, E.L.D. 
Fertility and Sterility 
Volume 101, Issue 4, Pages e1 (April 2014)
DOI: /j.fertnstert
Copyright © 2014 American Society for Reproductive Medicine Terms and Conditions

2. Figure 1 Study design flowchart.
Fertility and Sterility  , e1DOI: ( /j.fertnstert )
Copyright © 2014 American Society for Reproductive Medicine Terms and Conditions

3. Figure 2
(A and B) Follicles in a prepubertal ovary stained with hematoxylin and eosin (H&E) and TUNEL, respectively. (C) Adult femur stained with H&E. (D) Detail of the growth plate section stained with H&E (with computerized measurements). (E) Detail of the growth plate section stained with TUNEL.
Fertility and Sterility  , e1DOI: ( /j.fertnstert )
Copyright © 2014 American Society for Reproductive Medicine Terms and Conditions

4. Figure 3
Antimüllerian hormone (AMH) and follicle-stimulating hormone (FSH) serum levels and total follicle count at ages 56 days (A) and 92 days (B). *P<.05.
Fertility and Sterility  , e1DOI: ( /j.fertnstert )
Copyright © 2014 American Society for Reproductive Medicine Terms and Conditions

5. Supplemental Figure 1
Femur growth plate average thickness across the treatment groups at age 20 and 92 days.
Fertility and Sterility  , e1DOI: ( /j.fertnstert )
Copyright © 2014 American Society for Reproductive Medicine Terms and Conditions